Peritoneal Neoplasms - 29 Studies Found Completed : LUME-Ovar 1: Nintedanib (BIBF 1120) or Placebo in Combination With Paclitaxel and Carboplatin in First Line Treatment of Ovarian Cancer : Ovarian Neoplasms Peritoneal Neoplasms : 2009-11-09 : Drug: Placebo comparator to BI Completed : Clinical Trial of Docetaxel in Combination With Gemcitabine in Platinum-Resistant Ovarian Cancer and Primary Peritoneal Carcinoma : Ovarian Carcinoma Peritoneal Neoplasms : 2005-09-09 : Drug: Docetaxel and Gemcitabine Docetaxel 75 mg/m2 IV over 15-30 minutes on day 1 followed by Gemcitabin Completed : BIBF 1120 + Carboplatin/Pegylated Liposomal Doxorubicin (PLD) in Patients With Advanced Ovarian Cancer, Fallopian Tube Carcinoma or Primary Peritoneal Cancer : Ovarian Neoplasms Peritoneal Neoplasms : 2011-03-08 : Drug: BIBF 1120 + PLD 30 mg/m2 + CBDCA AUC5 mg/mL*min Recruiting : Adjuvant HIPEC in High Risk Colon Cancer : Colorectal Neoplasms Peritoneal Neoplasms : 2014-08-22 : Procedure: Adjuvant HIPEC (open/laparoscopic) Completed : Phase I Study of Continuous Hyperthermic Peritoneal Perfusion (CHPP) With Escalating Dose I.P. Platinum for Gastrointestinal Peritoneal Carcinomatosis : Peritoneal Neoplasms Stomach Neoplasms : 1999-11-03 : Procedure: CHPP with cisplatin Completed : Consumer-Based Activity Monitor in Evaluating and Measuring Activity of Older Patients With Abdominal Cancer Undergoing Surgery : Malignant Gastrointestinal Neoplasm Malignant Peritoneal Neoplasm : 2015-01-29 : Device: Management of Therapy Complications Fitbit Zip (portable pedometer d Recruiting : A Study of Atezolizumab Versus Placebo in Combination With Paclitaxel, Carboplatin, and Bevacizumab in Participants With Newly-Diagnosed Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer : Ovarian Cancer Fallopian Tube Cancer : 2017-01-30 : Drug: Paclitaxel Paclitaxel 17 Completed : Octreotide Compared to Placebo in Patients With Inoperable Bowel Obstruction Due to Peritoneal Carcinomatosis : Peritoneal Neoplasms Intestinal Obstruction Drug: Octreotide LAR Octreotid Completed : OVATURE (OVArian TUmor REsponse) A Phase III Study of Weekly Carboplatin With and Without Phenoxodiol in Patients With Platinum-Resistant, Recurrent Epithelial Ovarian Cancer : Fallopian Tube Cancer Peritoneal Neoplasms Drug: phenoxodiol 400mg phenox Active, not recruiting : Topotecan and Gefitinib (Iressa) for Ovarian, Peritoneal, or Fallopian Tube Cancer : Ovarian Cancer Peritoneal Neoplasms Drug: Topotecan <<< Previous | Next >>>